Acute paw oedema formation induced by ATP: Re-evaluation of the mechanisms involved

Inflammation Research

Volumn 45, Issue 2, 1996, Pages 96-102

  Ziganshina, L E ^a,b   Ziganshin, A U ^a,b   Hoyle, C H V ^a   Burnstock, G ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b KAZAN STATE MEDICAL UNIVERSITY   (Russian Federation)

Author keywords

ATP; Inflammation; Paw oedema; Purinoceptors

Indexed keywords

2 METHYLTHIOADENOSINE TRIPHOSPHATE; 3,7 DIMETHYL 1 PROPARGYLXANTHINE; 4,4' DIISOTHIOCYANATOSTILBENE 2,2' DISULFONIC ACID; 8 (4 SULFOPHENYL)THEOPHYLLINE; 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; ADENOSINE; ADENOSINE DIPHOSPHATE; ADENOSINE PHOSPHATE; ADENOSINE TRIPHOSPHATE; ALPHA,BETA METHYLENEADENOSINE TRIPHOSPHATE; ARGININE METHYL ESTER; CIBACRON BLUE F3GA; DIADENOSINE PENTAPHOSPHATE; DIADENOSINE TETRAPHOSPHATE; DIADENOSINE TRIPHOSPHATE; INDOMETACIN; KETANSERIN; PURINE RECEPTOR; PURINERGIC RECEPTOR STIMULATING AGENT; PYRIDOXALPHOSPHATE 6 AZOPHENYL 2',4' DISULPHONIC ACID; RANITIDINE; SURAMIN; TRIPROLIDINE; UNCLASSIFIED DRUG; URIDINE TRIPHOSPHATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; INFLAMMATION; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PAW EDEMA; TOPICAL DRUG ADMINISTRATION;

ADENOSINE TRIPHOSPHATE; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; EDEMA; HISTAMINE; INFLAMMATION; MALE; MICE; NG-NITROARGININE METHYL ESTER; RECEPTORS, PURINERGIC P1; RECEPTORS, PURINERGIC P2; SEROTONIN; SURAMIN;

EID: 0030063624     PISSN: 10233830     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02265122     Document Type: Article

References (39)

1. Hoyle CHV. Transmission: Purines. In: Burnstock G, Hoyle CHV, editors. Autonomic Neuroeffector Mechanisms. Chur: Harwood Academic Publishers, 1995;367-407.
2. 2-purinergic receptors for extracellular ATP and other nucleotides. Am J Physiol 1993;265:C577-606.
3. Burnstock G. Introduction: Changing face of autonomie and sensory nerves in the circulation. In: Edvinsson L, Uddman R, editors. Vascular Innervation and Receptor Mechanisms: New Perspectives. San Diego: Academic Press Inc. 1993:1-22.
4. Ialenti A, Ianaro A, Moncada S, Di Rosa M. Modulation of acute inflammation by endogenous nitric oxide. Eur J Pharmacol 1992;211:177-82.
5. Levine JD, Dardick SJ, Roizen MF, Helms C, Balsbaum AI. Contribution of sensory afferents and sympathetic efferents to joint injury in experimental arthritis. J Neurosci 1986;6: 3423-9.
6. Green PG, Basbaum AI, Helms C, Levine JD. Purinergic regulation of bradykinin-induced plasma extravasation and adjuvant-induced arthritis in the rat. Proc Natl Acad Sci USA 1991;8:4162-5.
7. Gordon JL. Extracellular ATP: effects, sources and fate. Biochem J 1986;223:309-19.
8. Milner P, Bodin P, Loesch A, Burnstock G. Rapid release of enothelin and ATP from isolated aortic endothelial cells exposed to increased flow. Biochem Biophys Res Commun 1990;170:649-56.
9. Walker BA, Hagenlocker BE, Douglas VK, Tarapchak SJ, Ward PA. Nucleotide response of human neutrophils. Lab Invest; 1991;64:105-12.
10. Leong WS, Russel RRG, Caswell AM. Induction of enhanced responsiveness of human articular chondrocytes to extracellular ATP by tumor necrosis factor-α. Clin Sci 1993;85:569-75.
11. 2Z receptor of human macrophage cells. Characterization and possible physiological role. J Clin Invest 1995;95:1207-16.
12. Tomita K, Ichikawa A, Hayashi H. Effects of cyclic 3′,5′-adenosine monophosphate on inflammations induced by inorganic pyrophosphate, ATP and other phlogistins. Jpn J Pharmacol 1972; 22(Suppl):8.
13. Oyanagui Y. Role of phosphate, pyrophosphate, adenine nucleotides and sulfate in activating production of the superoxide radical macrophages, and information of rat paw edema. Agents Actions 1977;7:125-32.
14. Foreman JC, Jordan CC. Comparisons of the activities of some peptides in human skin and as histamine releasing agents. Br J Pharmacol 1981;73:207P.
15. Oyanagui Y. Anti-inflammatory effects of polyamines in serotonin and carrageenin paw edemata - possible mechanism to increase vascular permeability inhibitory protein level which is regulated by glucocorticoids and superoxide radical. Agents Actions 1984;14:228-37.
16. Seale TW, Alba KA, Shamim MT, Carney JM, Daly JW. 3,7-Dimethyl-1-propargylxanthine: a potent and selective in vivo antagonist of adenosine analogs. Life Sci 1988;43:1671-84.
17. Nehlig A, Daval JL, Boyet S. Effects of selective adenosine A1 and A2 receptor agonists and antagonists on local rates of energy metabolism in the rat brain. Eur J Pharmacol 1994;258:57-66.
18. Perreti M, Harris JG, Flower RJ. A role of endogenous histamine in interleukin-8-induced neutrophil infiltration into mouse air-pouch: investigation of the modulatory action of systemic and local dexamethasone. Br J Pharmacol 1994;112:801-8.
19. Rinaldi-Carmona M, Congy C, Pointeau P, Vidal H, Breliere JC, Le-Fur G. Identification of binding sites for SR 46349B, a 5-hydroxytryptamine2 receptor antagonist, in rodent brain. Life Sci 1994;54:119-27.
20. Erdö F, Torok K, Aranyi P, Szekely JI. A new assay for antiphlogistic activity: Zymosan-induced mouse ear inflammation. Agent Actions 1993;39:137-42.
21. G-nitro arginine methyl ester (L-NAME) and flurbiprofen in the mouse. Br J Pharmacol 1992;106:493-7.
22. Neely CF, Matot I. A selective antagonist of P2X purinoceptor mediated vasoconstriction in the feline pulmonary vascular bed. Drug Dev Res 1994;31:302.
23. Welford LA, Cusack NJ, Hourani SMO. The structure-activity relationships of ectonucleotidases and excitatory P2-purinoceptors: evidence that dephosphorylation of ATP analogues reduces pharmacological potency. Eur J Pharmacol 1987;141:123-30.
24. Jaffar ZH, Pearce FL. Histamine secretion from mast cells stimulated with ATP. Agents Actions 1990;30:64-6.
25. 4- receptor that mediates permeabilisation of rat mast cells. Eur J Pharmacol 1988;147:13-21.
26. Collis MG, Hourani SMO. Adenosine receptor subtypes. Trends Pharmacol Sci 1993;14:360-6.
27. Ralevic V, Hoyle CHV, Burnstock G. Pivotal role of phosphate chain length in vasoconstrictor versus vasodilator actions of adenine dinucleotides in rat mesenteric arteries. J Physiol 1995;483.3:703-13.
28. Ogilvie A. Extracellular functions for ApnA. In: McLennan AG, editor. AP4A and other dinucleoside polyphosphates. Boca Raton: CRS Press, 1992;229-73.
29. Schlüter H, Offers E, Brüggemann G, van der Giet M, Tepel M, Nordhoff E, et al. Diadenosine phosphates and the physiological control of blood pressure. Nature 1994;367: 186-8.
30. O'Connor SE, Dainty IA, Leff P. Further subclassification of ATP receptors based on agonist studies. Trends Pharmacol Sci. 1991;12:137-41.
31. 2U purinergic receptors in dibutyryl cyclic AMP-differentiated HL60 cells. J Biol Chem 1992;267:6601-10.
32. Voogd TE, Vansterkenburg ELM, Wilting J, Janssen LHM. Recent research on the biological activity of suramin. Pharmacol Rev 1993;45:177-203.
33. Fletcher DS, Lin TY. Inhibition of immune complex-mediated activation of complement. Effect of agents modulating activation of, and the activated C1 complex. Inflammation 1980;4:113-23.
34. 2-purinoceptors in rat parotid acinar cells by isothiocyanate compounds. Biochem Pharmacol 1993;45:1936-40.
35. 2X-purinoceptors in rat vas deferens. Br J Pharmacol 1994;112:690-4.
36. Tauber AI, Goetzl AJ. Inhibition of complement-mediated functions of human neutrophils by impermeant stilbene disulfonic acids. J Immunol 1981;125:1786-9.
37. Korchak HM, Eisenstat BA, Hoffstein ST, Dunham PB, Weissmann G. Anion channel blockers inhibit lysosomal enzyme secretion from human neutrophils without affecting generation of superoxide anion. Proc Natl Acad Sci USA 1980;77:2721-5.
38. 2-purinoceptor-mediated responses. Eur J Pharmacol 1992;217:217-9.
39. Tonetti M, Sturla L, Bistofi T, Benatti U, De Flora A. Extracellular ATP potentiates nitric oxide synthase expression induced by lipopolysaccharide in Raw 64.7 murine macrophages. Biochem Biophys Res Commun 1994;203:430-5.